Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Símbolo de cotizaciónRDY
Nombre de la empresaDr Reddy's Laboratories Ltd
Fecha de salida a bolsaJan 01, 1986
Director ejecutivoAghanian (Patrick)
Número de empleados27811
Tipo de seguridadDepository Receipt
Fin del año fiscalJan 01
Dirección8-2-337, Road No.3 Banjara Hills
CiudadHYDERABAD
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísIndia
Código postal500-034
Teléfono914049002900
Sitio Webhttps://www.drreddys.com/
Símbolo de cotizaciónRDY
Fecha de salida a bolsaJan 01, 1986
Director ejecutivoAghanian (Patrick)